Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: 50-day-old baby died/ fetal death; The initial case was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on 28May2021, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient informed that after a week and three days (10 days) that she took the first dose of BNT162B2 vaccine, her 50-day-old baby died. She chose not to do curettage and wait for her body to notice fetal death. Obviously, she does not blame the vaccine beforehand because fetal death in the first trimester of pregnancy can have many reasons. However, knowing that research on the effects of the vaccine on embryos is still scarce, she would like to collaborate with this information so that pharmacists are aware and can, perhaps, prevent new cases, in the case of an adverse effect. Outcome of the event was unknown. The mother was pregnant at 1st trimester at the onset of the event. The fetal outcome is intrauterine death. Information on the lot/batch number has been requested.; Sender''s Comments: Event fetal death represents an intercurrent medical condition and unrelated to BNT162B2 .
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166